Addus HomeCare Corp Liquidation Value

ADUS Home Healthcare

Cash & Equivalents

$103.06M
As of 2026-03-31
Current Price: $90.98 (as of 2026-05-18)

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $206.13M
Total Obligations: -$322.55M
$-116.42M
Per share: $-6.24
Period: 2026-03-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $206.13M
AR: $144.82M
Total Obligations: -$322.55M
$28.40M
Per share: $1.52
Period: 2026-03-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $206.13M
AR: $144.82M
Inventory: N/A
Total Obligations: -$322.55M
$28.40M
Per share: $1.52
Period: 2026-03-31
incomplete 1 component missing — treated as $0 in formula. Why?
  • Inventory: not reported

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-116.42M$-6.24
Liquid Liquidation Value$28.40M$1.52
Operating Liquidation Value$28.40M$1.52

Key Components (as of 2026-03-31)

Data as of 2026-03-31 from 10-Q filed 2026-05-05. View on SEC EDGAR →

Cash & Equivalents$103.06M
Accounts Receivable$144.82M
InventoryN/A
Current Liabilities$149.47M
Long-term Debt (?)$91.27M
Op. Lease Liability (?)$34.33M
Finance Lease (?)N/A
Shares Outstanding18.7M

Explore all 114 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2026-03-31$103.06M$144.82MN/A$14.04M$149.47M$91.27M$34.33MN/A
2025-12-31$81.62M$151.69MN/A$16.83M$149.49M$120.96M$37.26MN/A
2025-09-30$101.92M$134.05MN/A$16.68M$156.80M$150.64M$38.81MN/A
2025-06-30$91.18M$140.10MN/A$15.69M$151.38M$169.06M$40.22MN/A

Comments

SEC Filings

PeriodFormFiledLink
2026-03-31 10-Q 2026-05-05 View
2025-12-31 10-K 2026-02-24 View
2025-12-31 10-K/A 2026-03-12 View
2025-09-30 10-Q 2025-11-04 View
2025-06-30 10-Q 2025-08-05 View
2025-03-31 10-Q 2025-05-06 View
2024-12-31 10-K 2025-02-25 View
2024-09-30 10-Q 2024-11-05 View

AI Insights

AI Insight·Generated 2026-05-06

Addus HomeCare Corp (ADUS) presents a deeply negative liquidation posture driven almost entirely by its goodwill-heavy balance sheet. As of March 31, 2026, total assets are $1.44B, but approximately $997M of that is goodwill (tagged at $996.7M) and $100.5M is net identifiable intangibles — together representing roughly 76% of total assets. Under the liquidation lens, both receive a 0% recovery haircut. Stripping out goodwill and intangibles, the remaining asset base is approximately $338.5M before applying further haircuts. Cash recovers at 100% ($103.1M), net AR at 90-95% (~$130-137M from $144.8M), PP&E at 50-70% (~$12-17M from $24.7M), and remaining current assets (prepaid/other ~$32M) at perhaps 30-40% or roughly $10-13M. Gross recoverable asset pool is therefore approximately $255-270M against total liabilities at face value of $319.5M. This yields a negative equity recovery of roughly negative $50-65M, consistent with MFFAIS's reported CLV of approximately negative $69M. The primary driver of this shortfall is the face-value liability stack — $94.3M revolving credit outstanding (maturing July 2028, bearing 5.43%), $47.5M in operating lease obligations (undiscounted future payments of $55.9M), $14.6M in deferred ARPA government stimulus advances (subject to recoupment risk if not properly expended), $44.2M net deferred tax liability, and standard accrued payroll/benefit liabilities of $63.9M accrued salaries, $13.4M workers' comp, $7.4M accrued insurance. The ARPA deferred liability ($14.6M, tagged as GovernmentAssistanceLiabilityCurrent) is notable: funds are subject to state recoupment if not expended on approved uses, making this a contingent incremental liability in liquidation. The prior-period filing provided was a 10-K/A amendment covering the year ended December 31, 2025 (filed March 12, 2026), containing only exhibits and no balance sheet data for direct comparison; however, the MD&A references debt declining from $124.3M at December 31, 2025 to $94.3M at March 31, 2026 following a $30M revolver paydown, which is a modest positive shift in the liability stack. Operating cash flow of $52.4M for Q1 2026 (versus $18.9M in Q1 2025) is operationally robust but does not alter the liquidation math since it depends on the business continuing to operate. Goodwill and intangibles account for substantially all of the gap between book equity ($1.12B) and liquidation recovery (negative). Filing discusses acquisition activity (Gold Horses Acquisition, Helping Hands Acquisition) in MD&A but does not separately tag acquisition consideration or contingent consideration in XBRL for this period.

Flags

Loading flags...

AI Insight Discussion

Loading...

Community Notes

Loading notes...

Questions

Loading questions...